Back to Search Start Over

Synthesis of "Naked" TeO 2 Nanoparticles for Biomedical Applications.

Authors :
Hesabizadeh T
Hicks E
Medina Cruz D
Bourdo SE
Watanabe F
Bonney M
Nichols J
Webster TJ
Guisbiers G
Source :
ACS omega [ACS Omega] 2022 Jun 30; Vol. 7 (27), pp. 23685-23694. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).
Publication Year :
2022

Abstract

Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO <subscript>2</subscript> NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherical with a diameter of around 70 nm. The energy band gap of those nanoparticles was determined to be around 5.2 eV. Moreover, TeO <subscript>2</subscript> NPs displayed a dose-dependent antibacterial effect against antibiotic-resistant bacteria such as multidrug-resistant Escherichia coli (MDR E. coli ) and methicillin-resistant Staphylococcus aureus (MR S. aureus ). The "naked" nature of the nanoparticle surface helped to eradicate the antibiotic-resistant bacteria at a very low concentration, with IC50 values of ∼4.3 ± 0.9 and 3.7 ± 0.2 ppm for MDR E. coli and MR S. aureus , respectively, after just 8 h of culture. Further, the IC50 values of the naked TeO <subscript>2</subscript> NPs against melanoma (skin cancer) and healthy fibroblasts were 1.6 ± 0.7 and 5.5 ± 0.2 ppm, respectively, for up to 72 h. Finally, to understand these optimal antibacterial and anticancer properties of the TeO <subscript>2</subscript> NPs, the reactive oxygen species generated by the nanoparticles were measured. In summary, the present in vitro results demonstrate much promise for the presently prepared TeO <subscript>2</subscript> NPs and they should be studied for a wide range of safe antibacterial and anticancer applications.<br />Competing Interests: The authors declare the following competing financial interest(s): The authors declare that the University of Arkansas at Little Rock has filled a provisional US patent on those tellurium dioxide nanoparticles.<br /> (© 2022 The Authors. Published by American Chemical Society.)

Details

Language :
English
ISSN :
2470-1343
Volume :
7
Issue :
27
Database :
MEDLINE
Journal :
ACS omega
Publication Type :
Academic Journal
Accession number :
35847343
Full Text :
https://doi.org/10.1021/acsomega.2c02316